Argenx Se (ARGX) Work In Process (2020 - 2024)
Argenx Se (ARGX) posted quarterly Work In Process of $37.2 million for Q2 2024, down 36.81% year-on-year from $58.8 million in Q3 2023, and down 21.06% on a QoQ basis from $47.1 million in Q4 2023.
Argenx Se (ARGX) Work In Process (2020 - 2024) Analysis & Trends
Argenx Se (ARGX) has reported Work In Process for 5 consecutive years, with $37.2 million the latest figure, recorded in Q2 2024.
- Quarterly Work In Process fell 36.81% year-over-year to $37.2 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $37.2 million (down 36.81% YoY) and the FY2023 annual result came in at $47.1 million, down 27.6% from the prior year.
- Work In Process declined to $37.2 million in Q2 2024 per ARGX's latest filing, from $47.1 million in the prior quarter.
- Over the last five years, Work In Process for ARGX reached as high as $65.0 million in Q4 2022 and fell as low as $6.1 million in Q4 2020.
- A 5-year average of $41.2 million and a median of $42.4 million in 2021 frame the typical range for Work In Process.
- Annual changes were most pronounced in 2021 — Work In Process surged 517.25% — and 2024, when it tumbled 36.81%.
- Year by year, Work In Process stood at $6.1 million in 2020, then jumped by 517.25% to $37.7 million in 2021, then jumped by 72.43% to $65.0 million in 2022, then slipped by 27.6% to $47.1 million in 2023, then declined by 21.06% to $37.2 million in 2024.
- According to Business Quant data, Work In Process over the past three periods registered $37.2 million, $47.1 million, and $58.8 million for Q2 2024, Q4 2023, and Q2 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 37.16 Mn |
| Dec 31, 2023 | 47.07 Mn |
| Jun 30, 2023 | 58.81 Mn |
| Dec 31, 2022 | 65.02 Mn |
| Jun 30, 2022 | 59.84 Mn |
| Dec 31, 2021 | 37.71 Mn |
| Jun 30, 2021 | 17.99 Mn |
| Dec 31, 2020 | 6.11 Mn |